
AMPHETAMINE SCREEN, URINE
Amphetamines are sympathomimetic amines that stimulate the CNS and supress appetite. They are a common cause of drug abuse. This assay confirms drug exposure of Amphetamines and its metabolites.
-
Pre-test Information:
No special preparation required
-
Report Delivery:
Daily
Related Products
-
PROPOXYPHENE SCREEN, URINE
0 out of 5Propoxyphene is a prescription drug for the relief of pain and is structurally related to Methadone. Drug overdose mainly affects the brain causing euphoria as well as analgesia, stupor, respiratory depression and coma. The half life of Propoxyphene is 8-24 hrs. This assay helps to monitor compliance and assess toxicity.
-
Pre-test Information:
No special preparation required
-
Report Delivery:
Daily
-
-
DESIPRAMINE
0 out of 5Desipramine is a tricyclic antidepressant used in the treatment of Enuresis (involuntary urination) in childhood and severe Obsessive Compulsive Neurosis. The assay is useful for monitoring serum concentration during therapy, evaluating potential toxicity and patient compliance.
-
Pre-test Information:
Recommended specimen: >12 hours post oral dose.
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
-
-
COCAINE & METABOLITE SCREEN, URINE
0 out of 5Cocaine is widely used by recreational drug abusers. This assay detects and confirms drug abuse involving cocaine. Presence of cocaine or its metabolite Benzoylecgonine in urine indicates use within the past 4 days. Since the half life of cocaine is 6 hrs, it will be present in urine 1 day after last use.
-
Pre-test Information:
No special preparation required
-
Report Delivery:
Daily
-
-
LAMOTRIGINE
0 out of 5Lamotrigine is used in the treatment of Bipolar I disorder and a wide variety of seizures including Primary generalized tonic clonic seizures and Partial seizures. It is also used to treat Migraine, Trigeminal neuralgia and Treatment refractory depression. This assay is used to monitor the blood levels, assess compliance and adjust dosage in patients receiving other anticonvulsant agents which interact pharmacokinetically with Lamotrigine.
-
Pre-test Information:
Recommended specimen: 0.5–1 hour before next dose at steady state
-
Report Delivery:
Sample by 7th of the month; Report after 2–3 weeks
-